-
UNDERSTANDING CEA CHARACTERISTICS ASSOCIATED WITH COST-SAVING FINDINGS
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF AN ALGORITHM TO IDENTIFY ASPIRIN USE FROM ELECTRONIC MEDICAL RECORDS AND CLAIMS DATA
Mar 18, 2026, 21:38 PM -
US MEDICINE PRICING POLICY CHANGES: IMPACT ON THE FULL BIOPHARMACEUTICAL INVESTMENT ECOSYSTEM
Mar 18, 2026, 21:38 PM -
EMPIRICAL TIME-SERIES ANALYSES IN THE PAST THREE DECADES 1991-2023 FOR IMMUNE THROMBOCYTOPENIA MEDICATIONS IN THE US MEDICAID PROGRAMS
Mar 18, 2026, 21:38 PM -
TEST-RETEST RELIABILITY OF CASE 1 BEST-WORST SCALING: EVIDENCE FROM RELATIVE ATTRIBUTE IMPORTANCE OF PREFERENCES FOR AI USE IN HEALTHCARE
Mar 18, 2026, 21:38 PM -
LONGITUDINAL ASSOCIATIONS OF CHEMOTHERAPY INDUCED SYMPTOM CLUSTERS WITH HEALTHCARE UTILIZATION AND MORTALITY AMONG PATIENTS WITH GASTROINTESTINAL CANCERS
Mar 18, 2026, 21:38 PM -
POPULATION HEALTH IMPACTS ASSOCIATED WITH NEW INDICATIONS: A CASE STUDY OF SGLT2-INHIBITORS
Mar 18, 2026, 21:38 PM -
THE BUDGET IMPACT OF INTRODUCING ZONGERTINIB INTO THE FORMULARY FOR TREATMENT-NAÏVE AND PRETREATED HER2-MUTANT ADVANCED NSCLC IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
ETHICAL AI DEPLOYMENT IN HEOR
Mar 18, 2026, 21:38 PM -
EFFECT OF CHINESE HERBAL MEDICINE COMBINED WITH CONVENTIONAL ANTI-OSTEOPOROTIC MEDICATION ON FRACTURE RISK IN OLDER ADULTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF SGLT2I, GLP-1, AND METFORMIN ON CARDIOVASCULAR OUTCOMES IN ADULTS WITH SEVERE MENTAL ILLNESS
Mar 18, 2026, 21:38 PM -
BREAKTHROUGH THERAPY (BT) AND FAST TRACK (FT) DESIGNATIONS IN NEW DRUG APPLICATIONS AND BIOLOGIC LICENSE APPLICATIONS (NDAS/BLAS) TO FDA’S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), 2013-2025
Mar 18, 2026, 21:38 PM -
CHOOSING PUBLIC LLMS AND AI AGENTS FOR PATIENT OUTCOMES RESEARCH: PRACTICAL PROS/CONS AND GOVERNANCE IMPLICATIONS
Mar 18, 2026, 21:38 PM -
THE COST-EFFECTIVENESS ANALYSIS OF INATICABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS IN CHINA
Mar 18, 2026, 21:38 PM -
ASSESSING THE IMPACT OF MISSINGNESS IN TREATMENT EFFECT MODIFIERS ON BIAS IN ANCHORED AND UNANCHORED MAIC AND STC
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF INCIDENT BRAIN METASTASES IN MEDICARE BENEFICIARIES WITH ALK+ METASTATIC NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
COMBINING DISCRETE CHOICE EXPERIMENT AND CONTINGENT VALUATION TO ESTIMATE WILLINGNESS-TO-PAY FOR LYME DISEASE VACCINE ATTRIBUTES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SUBCUTANEOUS MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN VERSUS RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN FOR UNITED STATES (US) PATIENTS WITH AUTOLOGOUS STEM CELL TRANSPLANT-INELIGIBLE RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
Mar 18, 2026, 21:38 PM -
ASSOCIATION OF FATIGUE AND ACUTE PAIN WITH HEALTH CARE RESOURCE UTILIZATION AND COSTS IN SICKLE CELL DISEASE IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
INCREASED RISK OF DIABETIC KETOACIDOSIS IN ADULTS WITH DELAYED DIAGNOSIS OF TYPE 1 DIABETES
Mar 18, 2026, 21:38 PM
